4//SEC Filing
Deschatelets Pascal 4
Accession 0001127602-25-015285
CIK 0001492422other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 1:19 PM ET
Size
6.5 KB
Accession
0001127602-25-015285
Insider Transaction Report
Form 4
Deschatelets Pascal
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2025-05-21$3.76/sh+12,780$48,053→ 1,160,496 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-21−12,780→ 0 totalExercise: $3.76Exp: 2026-02-06→ Common Stock (12,780 underlying)
Footnotes (1)
- [F1]This stock option was granted on 02/08/2016 and is fully vested.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001657720
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 1:19 PM ET
- Size
- 6.5 KB